HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Hou Selected Research

H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2

9/2015Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance.
3/2015Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer pain.
4/2014Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Hou Research Topics

Disease

79Neoplasms (Cancer)
05/2022 - 04/2002
48Infections
12/2021 - 05/2005
20Inflammation (Inflammations)
05/2022 - 09/2008
18Pain (Aches)
07/2022 - 05/2009
15Lung Neoplasms (Lung Cancer)
10/2022 - 11/2015
13COVID-19
02/2022 - 01/2020
11Neoplasm Metastasis (Metastasis)
12/2022 - 07/2002
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
10Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2006
10Virus Diseases (Viral Diseases)
07/2021 - 05/2005
9Breast Neoplasms (Breast Cancer)
12/2022 - 06/2011
9Fibrosis (Cirrhosis)
01/2021 - 08/2006
8Bone Neoplasms (Bone Cancer)
09/2015 - 03/2014
7Carcinogenesis
05/2022 - 09/2013
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 10/2009
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2014
6Diarrhea
01/2022 - 01/2019
6HIV Infections (HIV Infection)
07/2021 - 01/2014
6Hepatitis
06/2015 - 12/2005
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2021 - 07/2005
5Carcinoma (Carcinomatosis)
01/2021 - 06/2015
5Hyperalgesia
09/2015 - 04/2014
4Hemorrhage
06/2022 - 04/2007
4Radiation Pneumonitis
02/2022 - 02/2021
4Asthma (Bronchial Asthma)
08/2021 - 01/2011
4Periodontitis
04/2021 - 12/2014
4Poisoning
01/2021 - 05/2018
4Myopia
07/2018 - 07/2015
4Cancer Pain
10/2016 - 01/2014
4Type 2 Diabetes Mellitus (MODY)
08/2016 - 12/2013
3Adenocarcinoma
05/2022 - 12/2019
3Squamous Cell Carcinoma of Head and Neck
05/2022 - 04/2003
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 06/2011
3Acquired Immunodeficiency Syndrome (AIDS)
02/2022 - 11/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2020
3Lung Injury
10/2021 - 04/2008
3Periodontal Diseases (Periodontal Disease)
04/2021 - 12/2014
3Liver Diseases (Liver Disease)
01/2021 - 11/2005
3Vomiting
01/2021 - 10/2016
3Melanoma (Melanoma, Malignant)
01/2021 - 01/2018
3Nausea
01/2021 - 10/2016
3Human Influenza (Influenza)
01/2021 - 08/2013
3Opioid-Related Disorders (Opiate Addiction)
01/2021 - 01/2020
3Osteoporosis
12/2020 - 06/2010
3Chronic Hepatitis B
11/2020 - 07/2005
3Pneumonia (Pneumonitis)
04/2020 - 12/2014
3Disease Progression
01/2020 - 10/2016

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
05/2022 - 07/2002
17Pharmaceutical PreparationsIBA
12/2021 - 02/2009
15Messenger RNA (mRNA)IBA
05/2022 - 07/2002
15Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2015
14Antiviral Agents (Antivirals)IBA
11/2021 - 08/2005
10Biological ProductsIBA
11/2022 - 05/2008
10RNA (Ribonucleic Acid)IBA
05/2022 - 12/2008
9MicroRNAs (MicroRNA)IBA
08/2021 - 01/2009
9InterferonsIBA
02/2021 - 08/2005
8C-Reactive ProteinIBA
10/2021 - 07/2016
8Opioid Analgesics (Opioids)IBA
09/2021 - 03/2013
7EnzymesIBA
12/2021 - 02/2000
6CytokinesIBA
12/2019 - 08/2013
6Analgesics (Analgesic Drugs)IBA
10/2016 - 08/2010
5LipopolysaccharidesIBA
12/2021 - 09/2014
5Interleukin-6 (Interleukin 6)IBA
10/2021 - 08/2016
5Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021 - 09/2014
5Hemoglobins (Hemoglobin)IBA
01/2021 - 07/2010
5Ointments (Pastes)IBA
01/2020 - 08/2010
5CateninsIBA
01/2020 - 10/2011
5VaccinesIBA
01/2020 - 05/2005
5Indicators and Reagents (Reagents)IBA
01/2019 - 10/2009
5Morphine (MS Contin)FDA LinkGeneric
10/2016 - 03/2013
5PAR-2 ReceptorIBA
09/2015 - 01/2014
4Amino AcidsFDA Link
05/2022 - 04/2002
4CarbohydratesIBA
05/2022 - 01/2010
4Glutamate DehydrogenaseIBA
01/2022 - 01/2017
4GlutaminaseIBA
12/2021 - 01/2017
4LigandsIBA
12/2021 - 11/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 01/2021
4ProcalcitoninIBA
10/2021 - 11/2016
4AlbuminsIBA
10/2021 - 07/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2005
4Glutamine (L-Glutamine)FDA Link
01/2021 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2008
4kushenIBA
03/2016 - 10/2011
4AntigensIBA
06/2015 - 01/2011
3Interleukin-8 (Interleukin 8)IBA
10/2021 - 11/2017
3beta-lapachoneIBA
06/2021 - 11/2019
3Tyrosine (L-Tyrosine)FDA Link
01/2021 - 12/2005
3Angiogenesis InhibitorsIBA
01/2021 - 12/2017
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 06/2010
3AntioxidantsIBA
01/2021 - 03/2010
3AntibodiesIBA
11/2020 - 11/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 06/2019

Therapy/Procedure

51Therapeutics
05/2022 - 04/2003
14Drug Therapy (Chemotherapy)
10/2022 - 02/2005
10Radiotherapy
10/2022 - 03/2014
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2010
6Injections
02/2022 - 01/2020
4Artificial Respiration (Mechanical Ventilation)
06/2022 - 07/2016
3Immunotherapy
01/2021 - 01/2016
3Aftercare (After-Treatment)
01/2021 - 06/2010